Literature DB >> 8694734

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.

D Husain1, J W Miller, N Michaud, E Connolly, T J Flotte, E S Gragoudas.   

Abstract

OBJECTIVE: To compare the effectiveness of photodynamic therapy to close experimental choroidal neovascularization using an intravenous infusion of liposomal benzoporphyrin derivative (verteporfin) with previous work using a rapid intravenous injection, before initiating clinical trials.
METHODS: Choroidal neovascularization was induced in cynomolgus monkey eyes using argon laser. Liposomal benzoporphyrin derivative was delivered by an intravenous infusion pump for 10 or 32 minutes at a dose of 0.375 mg/kg. Irradiation was performed with 689- or 692-nm laser light (600-mW/cm2 irradiance and 150-J/cm2 fluence) in 7 normal eyes and 11 eyes with choroidal neovascularization between 30 and 105 minutes after the start of dye infusion. Findings were documented by fundus photography, fluorescein angiography, and light and electron microscopy.
RESULTS: Irradiation within 32 to 50 minutes of the start of the fast (10 minutes) or slow (32 minutes) dye infusion resulted in closure of choroidal neovascularization. In normal eyes, this technique caused choriocapillaris closure and retinal pigment epithelium damage with minimal damage to surrounding tissues.
CONCLUSION: Photodynamic therapy using intravenous infusion of liposomal benzoporphyrin derivative selectively closed experimental choroidal neovascularization. This may be a suitable modality for clinical use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694734     DOI: 10.1001/archopht.1996.01100140186012

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  26 in total

Review 1.  Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors:  G Soubrane; N M Bressler
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002.

Authors:  Joan W Miller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-11       Impact factor: 3.117

3.  The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularization.

Authors:  Libin Jiang; Chenjin Jin; Feng Wen; Shizhou Huang; Dezheng Wu; Lezheng Wu
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

Review 4.  Choroidal neovascularisation in pathological myopia: an update in management.

Authors:  W-M Chan; M Ohji; T Y Y Lai; D T L Liu; Y Tano; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

5.  Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys.

Authors:  Kunbei Lai; Chenjin Jin; Shu Tu; Yunfan Xiong; Rui Huang; Jian Ge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-05       Impact factor: 3.117

6.  Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells.

Authors:  Stephan Hoffmann; Stephanie Balthasar; Ulrike Friedrichs; Marianne Ehren; Stephen J Ryan; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-09       Impact factor: 3.117

Review 7.  Vascular endothelial growth factor and ocular neovascularization.

Authors:  J W Miller
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  [Transient visual decrease after photodynamic therapy].

Authors:  S Mennel; N Hausmann; C H Meyer; S Hörle; S Peter
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

9.  Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Authors:  Joan W Miller
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration.

Authors:  A M Armbrecht; P A Aspinall; B Dhillon
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.